Largest study of hemodynamically supported high-risk pci patients finds more complete revascularization with impella leads to improved outcomes

Abiomed (nasdaq: abmd) announces new protect iii study data that demonstrates reduced rates of macce (composite of death, stroke, myocardial infarctio

ABMD Ratings Summary

ABMD Quant Ranking